Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they controlEmanuele de Rinaldis, Andrew Tutt, Lars Holmberg et al.|BMC Genomics|2013Cited by 87
Functional and prognostic significance of the genomic amplification of frizzled 6 (<i><scp>FZD6</scp></i>) in breast cancerGabriele Corda, Arturo Sala, Gianluca Sala et al.|The Journal of Pathology|2016Cited by 74
The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motilityTai Kiuchi, Tony Ng, Elena Ortíz-Zapater et al.|Science Signaling|2014Cited by 63
IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast CancersPierfrancesco Marra, Andrew Tutt, Sumi Mathew et al.|Cancer Research|2014Cited by 61
Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancerNirmesh Patel, Andrew Tutt, Daniel Weekes et al.|Nature Communications|2018Cited by 57